When is travel-health AI inference transportable? Mobility-conditioned admissibility for cross-border disease risk and decision support

BACKGROUND: Artificial intelligence is increasingly used for infectious disease surveillance, traveller risk assessment, outbreak forecasting and decision support. Travel creates a distinctive transportability problem because people move between epidemiological, geographic, climatic and healthcare contexts in which the conditions supporting an inference may change rapidly. METHODS: This conceptual/theoretical methodological-development study was informed by a targeted narrative review of travel medicine, infectious disease surveillance, human mobility, border health, mass gatherings, antimicrobial resistance and health-AI validation literature. RESULTS: We develop a mobility-conditioned admissibility framework that treats travel as movement across origin, transit, destination and return regimes. Interpretation is conditioned on mobility state, epidemiological regime, exposure history, time-dependent constraints and clinical or biological constraints. Five proposed operational states are retained: supported inference, conditionally transportable inference, active monitoring, restricted interpretation and withholding. The framework also distinguishes low probability from infeasibility and requires preservation of rare but epidemiologically feasible events. CONCLUSIONS: Model availability and conventional predictive validity do not establish inferential transportability across changing travel contexts. Mobility-conditioned admissibility provides a complementary use-boundary layer for travel health AI by making cross-regime support explicit before outputs are interpreted or released. Its incremental value requires prospective evaluation against calibrated uncertainty, external validation and dataset-shift monitoring.

Authors

Institutions

Publication Details

Journal
Travel Medicine and Infectious Disease
Published
2026-10-16
DOI
https://doi.org/10.1016/j.tmaid.2026.103032
Primary Topic
Travel-related health issues
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

When is travel-health AI inference transportable? Mobility-conditioned admissibility for cross-border disease risk and decision support

Adegoke Olusegun Adefolalu
Travel Medicine and Infectious Disease
Travel-related health issues
article

When is travel-health AI inference transportable? Mobility-conditioned admissibility for cross-border disease risk and decision support

Adegoke Olusegun Adefolalu
article en

Abstract

BACKGROUND: Artificial intelligence is increasingly used for infectious disease surveillance, traveller risk assessment, outbreak forecasting and decision support. Travel creates a distinctive transportability problem because people move between epidemiological, geographic, climatic and healthcare contexts in which the conditions supporting an inference may change rapidly. METHODS: This conceptual/theoretical methodological-development study was informed by a targeted narrative review of travel medicine, infectious disease surveillance, human mobility, border health, mass gatherings, antimicrobial resistance and health-AI validation literature. RESULTS: We develop a mobility-conditioned admissibility framework that treats travel as movement across origin, transit, destination and return regimes. Interpretation is conditioned on mobility state, epidemiological regime, exposure history, time-dependent constraints and clinical or biological constraints. Five proposed operational states are retained: supported inference, conditionally transportable inference, active monitoring, restricted interpretation and withholding. The framework also distinguishes low probability from infeasibility and requires preservation of rare but epidemiologically feasible events. CONCLUSIONS: Model availability and conventional predictive validity do not establish inferential transportability across changing travel contexts. Mobility-conditioned admissibility provides a complementary use-boundary layer for travel health AI by making cross-regime support explicit before outputs are interpreted or released. Its incremental value requires prospective evaluation against calibrated uncertainty, external validation and dataset-shift monitoring.

Travel Medicine and Infectious DiseaseVol. 74
Sefako Makgatho Health Sciences University (ZA)
Good health and well-being
Openalex Percentile: Top 10%
Travel-related health issues
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.